A ground-breaking new trial at Imperial College London sees, for the first time ever under controlled conditions, a psychedelic drug tested head-to-head against a standard antidepressant as a treatment for depression. The film follows a pioneering team of scientists and psychotherapists as they compare the effects of psilocybin (the active ingredient of magic mushrooms) with an antidepressant on a small group of participants with clinical depression. This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression. How do psychedelic drugs measure up against the industry-standard antidepressants that have been popular since the 1990s? The empirical results of the trial are explored alongside the participants’ powerful lived experience.
In the second part and conclusion, a spotlight on the mass marketing of the synthetic opioid fentanyl examines the connections between drug manufacturers and government policy. Video of sales retreats and promotional material reveals a deep cynicism among company employees and a disregard for the widespread, nefarious corporate practices.
This series is a searing indictment of Big Pharma and the political operatives and government regulations that enable over-production, reckless distribution and abuse of synthetic opiates. Exploring the origins, extent and fallout of one of the most devastating public health tragedies of our time, with half a million deaths from overdoses this century alone, the film reveals that America's opioid epidemic is not a public health crisis that came out of nowhere. In the first part, a look at how Purdue Pharma worked with the FDA to get OxyContin approved for wider use, promoting the highly profitable pain medication's safety without sufficient evidence, and creating a campaign to redefine pain and how it's treated.
Some 30 million Americans have sent their DNA to be analysed by companies like 23andMe and AncestryDNA. But what happens once the sample is in the hands of testing companies, and how accurate are their results? The film explores the power of genetic data to reveal family connections, ancestry, and health risks—and even solve criminal cold cases.
Trailblazing scientists are making ground-breaking discoveries in the rapidly evolving world of genetic engineering. Technologies like CRISPR are making it possible to quickly and cheaply change the DNA of all living things, including humans. Today, genes can be edited almost as easily as words on a computer screen. This new ability to alter our DNA holds the promise of curing disease , saving threatened species, solving the problem of world hunger and maybe even obtaining human perfection. But will the promise be fulfilled and at what cost? The ability to gain control of our DNA is ground-breaking and revolutionary but there are varying opinions among scientists as to how the technology should be used responsibly. This documentary follows the science as it progresses at a breakneck speed.
This is the dramatic global story of the first year of COVID-19, tracing the devastation caused by the spread of the virus across four continents. The way in which this coronavirus became COVID-19, transmission from animals to humans, is going on all the time. Habitat loss and live animal trading around the world that foster this is continuing. And therefore, we've got to expect that this will happen again.
This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression. How do psychedelic drugs measure up against the industry-standard antidepressants that have been popular since the 1990s? The empirical results of the trial are explored alongside the participants’ powerful lived experience.